en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2023
vol. 98
 
Share:
Send email
Share:
abstract:
Original paper

Evaluation of MMP-1 and TIMP-1 expression in eosinophilic esophagitis and their usefulness in making therapeutic decisions – a preliminary study

Katarzyna Zdanowicz
1
,
Artur Rycyk
1
,
Joanna Reszec
1
,
Monika Skubis-Zalewska
1
,
Dariusz Marek Lebensztejn
1
,
Urszula Daniluk
1

  1. Medical University of Bialystok, Bialystok, Poland
Pediatr Pol 2023; 98 (4): 293-299
DOI: https://doi.org/10.5114/polp.2023.133532
Online publish date: 2023/12/15
View full text Get citation
 
PlumX metrics:
Introduction
The incidence of eosinophilic esophagitis (EoE) is rapidly increasing in both children and adults. However, despite extensive research, data on disease pathogenesis and useful markers for predicting treatment response are still lacking. The aim of the study was to analyze matrix metalloproteinase-1 (MMP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression in the esophagus of pediatric patients with EoE.

Material and methods
This single-center study included newly diagnosed children with EoE based on endoscopic and histopathological results, children with esophageal eosinophilia (EE) not meeting the EoE criteria and healthy controls. Immunohistochemistry for MMP-1 and TIMP-1 was performed.

Results
Among the 30 children whose biopsy specimens were evaluated, 10 patients were diagnosed with EoE, 10 patients with EE and 10 were healthy controls. Weak expression of MMP-1 in esophageal samples was observed in half or more cases in each group. However, strong MMP-1 expression was noted in half of EoE patients before treatment with a decrease in number of cases after treatment. Interestingly, lack of TIMP-1 expression was noted in all EoE patients, in contrast to EE samples, or control cases. Children with strong MMP-1 expression at the time of EoE diagnosis appeared to respond less well to proton pump inhibitors (PPIs) either alone or in combination with an elimination diet. There were no differences in MMP-1 expression with PPI monotherapy as opposed to combination therapy.

Conclusions
Our data revealed that children with EoE did not express TIMP-1 in esophageal tissue, unlike EE and healthy controls. More intense expression of MMP-1 at diagnosis was associated with a poor response to treatment.

keywords:

children, MMP-1, proton pump inhibitors, TIMP-1, eosinophilic esophagitis